Ponday, Ronald D.
HRN: 26-93-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2025
CEFTAZIDIME 1GM (VIAL)
04/08/2025
04/15/2025
IV
2g
Q8
CAP-HR (hypotension), PTB Presumptive
Waiting Final Action
Indication: EmpiricEmpirical De-escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes